GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hester Biosciences HESTERBIO.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

2,308.90

-2.64%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹3.33bn

FY2017FY2026

Net income

₹556.4m

FY2017FY2026

Free cash flow

₹417.0m

FY2017FY2026

Shareholders' equity

₹3.60bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹3.33bn₹3.11bn₹3.05bn₹2.66bn₹2.35bn₹2.14bn₹1.83bn₹1.78bn₹1.36bn₹1.23bn
Research and development—₹59.5m₹46.6m₹33.9m—₹10.2m₹24.0m₹31.7m₹28.8m₹28.3m
Operating income₹787.1m₹455.1m₹364.8m₹412.3m₹575.7m₹567.8m₹468.6m₹625.8m₹395.7m₹307.9m
Net income₹556.4m₹274.9m₹188.9m₹266.3m₹393.2m₹344.3m₹291.7m₹415.7m₹256.2m₹234.5m
Diluted earnings per share65.4032.3121.7231.3046.2240.4734.2948.8630.1227.56

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹6.78bn₹6.53bn₹6.62bn₹5.46bn₹5.62bn₹4.11bn₹3.84bn₹2.99bn₹2.44bn₹2.18bn
Cash and short-term investments₹65.4m₹72.2m₹153.0m₹226.1m₹252.2m₹212.7m₹230.9m₹416.7m₹130.8m₹119.6m
Total liabilities₹3.10bn₹3.27bn₹3.59bn₹2.53bn₹2.95bn₹1.75bn₹1.78bn₹1.18bn₹990.4m₹939.4m
Debt₹1.95bn₹2.13bn₹2.44bn₹2.71bn₹2.28bn₹1.10bn₹1.26bn₹898.5m₹687.8m₹629.4m
Shareholders' equity₹3.60bn₹3.14bn₹2.92bn₹2.92bn₹2.60bn₹2.28bn₹2.01bn₹1.77bn₹1.41bn₹1.20bn
Shares outstanding9m9m9m9m9m9m9m9m9m9m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹595.3m₹645.1m₹481.3m₹236.0m₹88.1m₹580.5m₹382.9m₹482.1m₹380.2m₹348.0m
Capital spending−₹178.3m−₹205.9m−₹244.0m−₹777.6m−₹957.1m−₹407.4m−₹735.0m−₹226.5m−₹229.7m−₹302.4m
Free cash flow₹417.0m₹439.2m₹237.4m−₹541.7m−₹869.0m₹173.1m−₹352.1m₹255.6m₹150.5m₹45.5m
Dividends paid−₹60.3m−₹51.7m−₹68.0m−₹85.1m−₹85.1m−₹56.1m−₹71.8m−₹102.6m−₹64.5m−₹34.9m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹772.4m₹1.00bn₹774.1m₹709.7m₹841.0m₹819.3m₹632.2m₹836.9m
Operating income₹157.3m₹284.2m₹151.8m₹73.6m₹220.0m₹93.7m₹7.7m₹149.6m
Net income₹969.8m₹159.8m₹87.7m₹144.5m₹164.4m₹12.9m₹116.6m₹82.0m
Diluted earnings per share114.0018.7910.3016.9919.331.5213.419.43
Cash from operations———₹174.0m—₹645.0m—₹241.0m
Capital spending———−₹83.0m—−₹205.0m—−₹129.0m
Free cash flow———₹91.0m—₹440.0m—₹112.0m
Total assets—₹6.78bn—₹6.75bn—₹6.53bn—₹6.69bn
Cash and short-term investments₹65.4m₹65.4m₹79.4m₹281.6m₹72.2m₹72.2m₹167.9m₹167.9m
Debt—₹1.89bn—₹2.14bn—₹2.13bn—₹2.44bn
Shareholders' equity₹3.68bn₹3.60bn₹3.51bn₹3.38bn₹3.27bn₹3.14bn₹3.14bn₹3.02bn

Financial ratios

Data as of 2 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin23.7%14.6%12.0%15.5%24.5%26.5%——
Net margin16.7%8.8%6.2%10.0%16.7%16.1%——
Return on equity15.4%8.7%6.5%9.1%15.1%15.1%——
Return on assets8.2%4.2%2.9%4.9%7.0%8.4%——
Free cash flow yield4.3%4.7%3.9%5.6%5.8%5.5%——
Revenue growth6.9%2.2%14.5%13.2%9.6%16.9%——
Earnings growth102.4%45.5%-29.1%-32.3%14.2%18.0%——
Current ratio1.37x1.56x2.03x1.58x2.01x2.63x——
Debt to equity0.52x0.66x0.82x0.56x0.86x0.46x——
Equity ratio53.1%48.1%44.1%53.6%46.2%55.5%——
Interest coverage7.20x3.58x3.87x7.52x16.29x8.60x——
R&D as a share of sales—1.9%1.5%1.3%—0.5%1.3%1.8%
Buybacks as a share of market value0.0%2.2%-2.2%0.0%0.0%0.0%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue7.7%9.2%12.7%
Operating income24.1%6.7%12.5%
Net income27.8%10.1%11.4%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin19.3%16.6%19.0%21.8%
Net margin12.9%10.6%12.2%14.3%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings35.349.5110.546.638.862.649.829.737.567.3
Price to sales5.94.46.84.76.510.17.96.97.112.8

Dividends and splits

Per share, in the currency the company pays

Paid for 11 years. Last went ex-dividend on 6 Aug 2025.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year7.006.008.0010.0010.006.607.0010.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.